BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 26423666)

  • 1. Expression and Significance of COX-2 and Ki-67 in Hepatolithiasis with Bile Duct Carcinoma.
    Wang P; He Y; Ma X; Sun B; Huang B; Zhu C; Liu Y
    Med Sci Monit; 2015 Oct; 21():2943-9. PubMed ID: 26423666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Result of p53, ki-67 protein expression in cholangiocarcinoma with in situ hybridization and immunohistochemistry methods].
    Wang X; Zhang J; Chen J
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2000 Feb; 22(1):57-60. PubMed ID: 12903495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of p53 and Ki-67 expression in resected or biopsy specimens of bile duct carcinoma.
    Murakami M; Sasaki T; Kuwada Y; Yamasaki S; Kuwahara K; Chayama K
    Oncol Rep; 2003; 10(5):1091-6. PubMed ID: 12883663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. c-erbB-2 protein is expressed in hepatolithiasis and cholangiocarcinoma.
    Terada T; Ashida K; Endo K; Horie S; Maeta H; Matsunaga Y; Takashima K; Ohta T; Kitamura Y
    Histopathology; 1998 Oct; 33(4):325-31. PubMed ID: 9822921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Down stream involvement of the bile duct in hepatolithiasis.
    Lu S; Yan L; Rao L; Xia T; Gou J; Zhang S; Lei S
    Chin Med J (Engl); 2002 Jan; 115(1):62-4. PubMed ID: 11930661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Silver-binding nucleolar organizer regions in hepatolithiasis and bile duct cancer.
    Ker CG
    Proc Natl Sci Counc Repub China B; 1997 Apr; 21(2):43-8. PubMed ID: 9276966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of the expression of p53, MIB-1 (Ki-67 antigen), and argyrophilic nucleolar organizer regions in carcinoma of the extrahepatic bile duct.
    Suto T; Sugai T; Nakamura S; Funato O; Nitta H; Sasaki R; Kanno S; Saito K
    Cancer; 1998 Jan; 82(1):86-95. PubMed ID: 9428483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and clinical significance of the G1-S modulators in carcinoma of the extrahepatic bile duct.
    Ito Y; Takeda T; Sakon M; Monden M; Tsujimoto M; Matsuura N
    Anticancer Res; 2000; 20(1A):337-44. PubMed ID: 10769677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bile duct expression of pancreatic and duodenal homeobox 1 in perihilar cholangiocarcinogenesis.
    Igarashi S; Matsubara T; Harada K; Ikeda H; Sato Y; Sasaki M; Matsui O; Nakanuma Y
    Histopathology; 2012 Aug; 61(2):266-76. PubMed ID: 22594685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential expression of basement membrane type IV collagen α2 and α6 chains as a prognostic factor in patients with extrahepatic bile duct carcinoma.
    Hirashima K; Iyama K; Baba Y; Honda Y; Sado Y; Ninomiya Y; Watanabe M; Takamori H; Beppu T; Baba H
    J Surg Oncol; 2013 Mar; 107(4):402-7. PubMed ID: 22927259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EGFR, COX2, p-AKT expression and PIK3CA mutation in distal extrahepatic bile duct carcinoma.
    Moon A; Chin S; Kim HK; Kwak JJ; Koh ES; Kim YW; Jang KT
    Pathology; 2016 Jan; 48(1):35-40. PubMed ID: 27020207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevation of carcinoembryonic antigen related to biliary malignancy in hepatolithiasis.
    Ker CG; Sheen PC; Chien CH; Wu CC
    Surg Today; 1993; 23(6):496-9. PubMed ID: 8358193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of c-erbB-2 and cyclooxygenase-2 in intrahepatic cholangiocarcinoma.
    Choi HJ; Kim HJ; Choi JH
    Hepatogastroenterology; 2009; 56(91-92):606-9. PubMed ID: 19621664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential expression of cyclooxygenase-2 (COX-2) in human bile duct epithelial cells and bile duct neoplasm.
    Hayashi N; Yamamoto H; Hiraoka N; Dono K; Ito Y; Okami J; Kondo M; Nagano H; Umeshita K; Sakon M; Matsuura N; Nakamori S; Monden M
    Hepatology; 2001 Oct; 34(4 Pt 1):638-50. PubMed ID: 11584358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A study of CEA, CA 19-9 and CA 125 in biliary tract diseases.
    Ker CG; Wu CC; Chen JS; Hou MF; Lee KT; Sheen PC
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1989 Feb; 5(2):107-13. PubMed ID: 2733069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression of epidermal growth factor receptor, ErbB2 and matrix metalloproteinase-9 in hepatolithiasis and cholangiocarcinoma].
    Kim HJ; Kim JS; Kang CD; Lee SJ; Kim JY; Yeon JE; Park JJ; Shim JJ; Byun KS; Bak YT; Lee CH
    Korean J Gastroenterol; 2005 Jan; 45(1):52-9. PubMed ID: 15665568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and clinical significance of cell cycle regulatory proteins in gallbladder and extrahepatic bile duct cancer.
    Kim WB; Han HJ; Lee HJ; Park SS; Song TJ; Kim HK; Suh SO; Kim YC; Choi SY
    Ann Surg Oncol; 2009 Jan; 16(1):23-34. PubMed ID: 18979138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of cyclooxygenase-2 in cholangiocarcinoma: correlation with clinicopathological features and prognosis.
    Kim HJ; Lee KT; Kim EK; Sohn TS; Heo JS; Choi SH; Choi DI; Lee JK; Paik SW; Rhee JC
    J Gastroenterol Hepatol; 2004 May; 19(5):582-8. PubMed ID: 15086604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of c-erbB-2 proto-oncogene in extrahepatic cholangiocarcinoma and its clinical significance.
    Zheng J; Zhu YM
    Hepatobiliary Pancreat Dis Int; 2007 Aug; 6(4):412-5. PubMed ID: 17690040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined analysis of cyclooxygenase-2 expression with p53 and Ki-67 in nonsmall cell lung cancer.
    Tsubochi H; Sato N; Hiyama M; Kaimori M; Endo S; Sohara Y; Imai T
    Ann Thorac Surg; 2006 Oct; 82(4):1198-204. PubMed ID: 16996907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.